You are here

Vaccines

Primary tabs

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Members

Kathy Gilbeaux mdmcdonald MDMcDonald_me_com mike kraft

Email address for group

vaccines_global@m.resiliencesystem.org

Poll: Number of Americans who plan to get vaccinated falls to 42% — a new low

So far, most of the conversation about COVID-19 vaccines has focused on the question of whether researchers can develop an effective vaccine in record time. 

But maybe we should start asking another question as well: Will enough Americans actually get the vaccine for it to be effective? 

“It’s not a vaccine that will save us,” says Harvard Global Health Institute director Ashish Jha. “It’s vaccination.” 

Problem, Solution, SitRep, or ?: 

Johnson & Johnson’s Coronavirus Vaccine Protects Monkeys, Study Finds

An experimental coronavirus vaccine developed by Johnson & Johnson protected monkeys from infection in a new study. It is the second vaccine candidate to show promising results in monkeys this week.

The company recently began a clinical trial in Europe and the United States to test its vaccine in people. It is one of more than 30 human trials for coronavirus vaccines underway across the world. But until these trials are complete — which will probably take several months — the monkey data offers the best clues to whether the vaccines will work.

Problem, Solution, SitRep, or ?: 

Scientists Worry About Political Influence Over Coronavirus Vaccine Project

 

In April, with hospitals overwhelmed and much of the United States in lockdown, the Department of Health and Human Services produced a presentation for the White House arguing that rapid development of a coronavirus vaccine was the best hope to control the pandemic.

“DEADLINE: Enable broad access to the public by October 2020,” the first slide read, with the date in bold.

Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.772 seconds.